drugset / Trial / NCT07645430
Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study was to evaluate the change in serum interferon gamma and Interleukin-15 levels before and after use of oral drug baricitinib therapy. Venous blood samples (5 mL) were collected from each participant at baseline and at six months.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2024-01-01
- Completion
- 2026-06-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Baricitinib | Small molecule | 4 mg | Oral |